IDEAS home Printed from https://ideas.repec.org/a/bla/ijhplm/v37y2022i3p1650-1662.html
   My bibliography  Save this article

The impact of National Centralised Drug Procurement policy on the use of policy‐related original and generic drugs in China

Author

Listed:
  • Ying Yang
  • Runhu Hu
  • Xin Geng
  • Lining Mao
  • Xiaotong Wen
  • Zhaolun Wang
  • Siyu Hao
  • Dan Cui
  • Zongfu Mao

Abstract

Aims To evaluate the effects of the first round of National Centralised Drug Procurement pilot (so‐called ‘4+7’ policy) on the use of policy‐related original and generic drugs. Methods This study used drug purchasing order data from the Centralised Drug Procurement Survey in Shenzhen 2019, covering 24 months from January 2018 to December 2019. ‘4+7’ policy‐related drugs were selected as study samples, including 25 drugs in the ‘4+7’ procurement list and 69 alternative drugs that have an alternative relationship with ‘4+7’ List drugs in clinical use. ‘4+7’ List drugs were then divided into bid‐winning and bid‐non‐winning products according to the bidding results. Included drugs were sorted into original and generic drugs. Purchase volume, expenditures, and daily costs were selected as outcome variables, and were measured using Defined Daily Doses (DDDs), Chinese Yuan (CNY), and Defined Daily Drug cost (DDDc). A single‐group Interrupted Time Series analysis was adopted to quantify policy effect. Results After policy intervention, the overall policy‐related original drugs significantly decreased by 0.39 CNY (95% CI: −0.62 to −0.17, p

Suggested Citation

  • Ying Yang & Runhu Hu & Xin Geng & Lining Mao & Xiaotong Wen & Zhaolun Wang & Siyu Hao & Dan Cui & Zongfu Mao, 2022. "The impact of National Centralised Drug Procurement policy on the use of policy‐related original and generic drugs in China," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(3), pages 1650-1662, May.
    • Handle: RePEc:bla:ijhplm:v:37:y:2022:i:3:p:1650-1662
    DOI: 10.1002/hpm.3429
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/hpm.3429
    Download Restriction: no
    File URL: https://libkey.io/10.1002/hpm.3429?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:ijhplm:v:37:y:2022:i:3:p:1650-1662. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0749-6753 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.